Companion Animal Diagnostics Market - By Product, By Technology, By Application, By Animal Type, By End Use - Global Forecast 2025 - 2034

Companion Animal Diagnostics Market Size

The global companion animal diagnostics market was valued at USD 2.4 billion in 2024. The market is anticipated to grow from USD 2.6 billion in 2025 to USD 5.8 billion in 2034, growing at a CAGR of 9.3% from 2025 to 2034. The market is experiencing considerable growth driven by increasing pet population globally, high adoption of pet animals for companionship, rising cases of infectious and chronic diseases in animals, and rising expenditure on veterinary care.
 

As per a recent study published by GlobalPET, there are over one billion animals kept as pets worldwide. The number of households with pets in the U.S., Brazil, Europe, and China alone has exceeded half a billion. Also, more than half of the world's families are said to have at least one pet. Such a high volume of pets increases the demand for various pet care products, thereby boosting market growth.

The rising trend of pet humanization and increased consumer spending on pet care products and veterinary services are major growth drivers. As owners increasingly consider pets as a part of their family, the average amount spent per household on pets is rising. For example, an average American pet owner spent USD 1,960 on their pet(s) in 2023. The average pet dog costs USD 143 per month in 2024, whereas cat ownership costs USD 90.5 per month per cat. As households increase their spending on pets, there is a higher demand for various pet care services, such as companion animal diagnostics, thereby fueling market growth.
 

Moreover, the increasing occurrence of zoonotic diseases as well as the possibility of infectious outbreaks in companion animals have been propelling the companion animal diagnostics market. There are policies pertaining to the health of animals due to concerns regarding their health and the spread of diseases. These policies have led to the implementation of several programs aimed at ensuring disease control. Regulatory authorities across the world are imposing strict policies to prevent the outbreak of animal borne diseases and propelling the use of animal diagnostic solutions, thus contributing to market growth. Further, several technological advancements in the field of veterinary medicine are set to positively influence the animal healthcare industry.
 

Companion animal diagnostics refer to the process of identifying, detecting, and monitoring diseases or health conditions in pets through various diagnostic tests. These tests may include blood and urine analysis, molecular diagnostic methods, serological assays, and other specialized examinations.
 

Companion Animal Diagnostics Market Trends

• High occurrence of zoonotic and other infectious diseases in animals is a major factor fueling the market. Increased prevalence of diseases such as canine distemper, parvovirus, rabies, kennel cough in dogs, and feline leukemia, feline immunodeficiency virus (FIV), and Feline infectious peritonitis (FIP) in cats severely endangers their health.
   
• For example, as per the Cornell University College of Veterinary Medicine, Feline leukemia virus (FeLV) is one of the most common and important infectious diseases in cats, affecting between 2-3% of all cats in the U.S. and Canada. Similarly, studies report that each year, about 400 to 500 cases of rabies are reported in domestic pets. As per the CDC, every year, rabies kills 70,000 people worldwide. Dogs cause 99% of human rabies deaths outside the U.S.
   
• Such a rising risk of zoonotic and infectious diseases has shifted focus toward preventive approaches, including extensive use of diagnostic solutions, which is set to positively drive the market growth.
   
• Also, the availability of advanced medical facilities for pets, cutting-edge medical devices, drugs, and pet insurance is further set to positively impact industry growth.
   
• The rising prevalence of several chronic diseases in animals, such as obesity, diabetes, and cancer, increases the demand for diagnostics and therapeutic modalities, further enhancing market growth. For instance, the Veterinary Cancer Society estimates that one in four dogs will be diagnosed with cancer in their lifetime, and that cancer is the leading cause of death in pets that are beyond middle age.
   
• Further, several initiatives by government and non-government bodies towards better animal welfare and safety propel market growth. For example, the U.S. Food and Drug Administration (FDA) has developed networks such as the Veterinary Laboratory Investigation and Response Network (Vet-LIRN). These networks connect veterinary laboratories across the country to monitor and investigate disease outbreaks. They provide crucial support for rapid disease detection and promote standardized diagnostic practices. As a result, the infrastructure needed to support animal health is improving, creating a foundation for increased adoption of diagnostics technologies.
   

Companion Animal Diagnostics Market Analysis

The market was valued at 2 billion in 2021. The market size reached USD 2.1 billion in 2022 and USD 2.3 billion in 2023.
 

Based on the product, the market is segmented into consumables and instruments. The consumables segment accounted for the highest market share and was valued at USD 2 billion in 2024.
 

• Unlike instruments, consumables such as kits, reagents, assays, blood collection tubes, slides, and other diagnostic supplies are used in every diagnostic test, leading to continuous replenishment needs. Hence, as the veterinary testing volume rises, so does the demand for these consumables. This ensures steady revenue and growth in the consumables segment.
   
• Also, with the growing trend of pet humanization, more owners are opting for preventive healthcare, which further drives up the usage of consumables in regular check-ups and early disease detection.
   
• Advancements in diagnostic technologies have led to the development of more specialized and accurate tests, many of which rely heavily on high-quality consumables. For instance, point-of-care testing, which allows rapid on-site diagnosis, relies on pre-packaged kits designed for single use, contributing significantly to market volume.
   
• Thus, as veterinary clinics and hospitals increasingly adopt these technologies, the demand for associated consumables is anticipated to rise, thereby driving the market growth.
   

Based on technology, the companion animal diagnostics market is segmented into clinical biochemistry, immunodiagnostics, molecular diagnostics, hematology, urinalysis, and other technologies. The clinical biochemistry segment dominated the market in 2024 and is anticipated to grow at a CAGR of 9.4% over the analysis timeframe.
 

• Clinical biochemistry tests are often performed in veterinary practice for the general welfare and organ function of companion animals. By testing blood and other body fluids, clinical biochemistry enables veterinarians to identify diseases such as diabetes, liver disease, kidney abnormalities, and electrolyte imbalance.
   
• These tests are conducted on a regular basis during wellness exams, pre-surgical exams, and in animals that show signs of illness. The wide usage of clinical biochemistry in a vast array of conditions makes it a central diagnostic methodology, propelling its strong demand in veterinary clinics.
   
• Increasing availability of advanced diagnostic equipment capable of delivering quick and accurate biochemical results further increases the adoption of these tests.
   
• Furthermore, increased awareness among pet owners regarding the advantages of early detection and continuous monitoring of health has driven demand for clinical biochemistry testing, thereby solidifying the segment's position in the overall market.
   

Based on the application, the companion animal diagnostics market is segmented into bacteriology, pathology, parasitology, and other applications. The bacteriology segment dominated in 2024 and is anticipated to reach USD 2.4 billion by end of 2034.
 

• The bacteriology segment holds a leading market share in the market by virtue of its essential function to detect bacterial infections that are typical of pet animals.
   
• Skin infections, urinary tract infections, respiratory infections, and gastrointestinal upsets often need to be diagnosed using bacterial culture and sensitivity testing in order to be diagnosed and treated correctly.
   
• In addition, developments in bacteriology like simplified culture procedures, quick antigen tests, and coupling with molecular technology have significantly enhanced the speed, precision, and value of these tests.
   
• These technological advances, coupled with increasing investment in animal health infrastructure, most notably reference labs and point-of-care facilities, have solidified bacteriology segment as a dominant position in the market.

Based on animal type, the companion animal diagnostics market is categorized into dogs, cats, horses, and other animal types. The dogs segment dominated the market in 2024 with a market share of 53.7%.
 

• The increasing segmental growth is attributed to the rising adoption rate of dogs as companion animals, coupled with growing expenditure on dogs.
   
• For instance, in 2021, according to the American Pet Products Association (APPA), 90.5 million families own a pet in the U.S., among which 69 million (over 76%) households own a dog.
   
• Countries in Europe such as UK, Poland, and France are noted to have some of the highest populations of pet dogs. Thus, the higher adoption rates along with increased spending are expected to propel the segmental growth.
   
• Further, the high incidence of chronic disease conditions such as diabetes, arthritis, chronic kidney disease, and heart disease in dogs is expected to accelerate market growth. Studies suggest that diabetes mellitus (DM) is a common complex endocrine disorder in dogs, which affects middle-aged to geriatric dogs.
   
• It is estimated that the prevalence of DM within the pet dog population ranges between 0.2% and 1.2% and is even higher in genetically predisposed breeds such as Samoyeds, Tibetan Terriers, Cairn Terriers, and others. The occurrence of such diseases necessitates routine diagnostic testing, thereby driving segmental growth.
   

Based on the end use, the companion animal diagnostics market is categorized into veterinary hospitals and clinics, diagnostic labs, home care settings, and other end users. The diagnostic labs segment dominated the market in 2024 and is anticipated to grow at a CAGR of 9.1% between 2025 - 2034.
 

• Diagnostic laboratories hold a dominant share in the market because of their sophisticated infrastructure, trained personnel, and capability to efficiently manage large sample volumes with high accuracy.
   
• These laboratories have advanced diagnostic systems like PCR machines, real-time PCR, and next-generation sequencing tools, which enable timely and precise identification of microorganisms, genetic alterations, and other associated markers in tissues and fluids from animals.
   
• Such capabilities make them a preferred partner for veterinarians and animal healthcare practitioners.
   
• Also, the increase in the number of pet owners has resulted in increased demands for regular health checks and disease surveillance, further accelerating the demand for centralized diagnostic lab testing.

North America dominates the global companion animal diagnostics market with a market size of USD 1 billion in 2024 and is anticipated to reach USD 2.3 billion by 2034, growing at a CAGR of 8.8% between 2025 - 2034.
 

The U.S. market was valued at USD 729.2 million and USD 778.5 million in 2021 and 2022, respectively. The market size reached USD 893.3 million in 2024, growing from USD 833.7 million in 2023.
 

• According to the 2021–2022 National Pet Owners Survey by the American Pet Products Association (APPA), 70% of the U.S. households owned at least one type of pet. Approximately 69 million of the U.S. households have at least one dog, and 45.3 million have at least one cat, about 9.9 million have birds, and 3.5 million have horses.
   
• High rates of pet ownership in the country, coupled with the availability of advanced diagnostic services, drive market growth.
   
• Additionally, rising expenditure on animal care and strong veterinary infrastructure increases the adoption of companion animal diagnostics.
   

Europe companion animal diagnostics market accounted for USD 724.4 million in 2024 and is anticipated to show considerable growth over the forecast period.
 

• As per the European Pet Food Industry, approximately 90 million households in the EU own a pet (~46%). This rise in animal adoption in the European region, coupled with increasing initiatives by the government to improve animal healthcare. Such a high volume of animal adoption is anticipated to increase product demand, thereby fostering regional market growth.
   
• Also, the presence of key market players such as IDEXX Laboratories, Zoetis, and Virbac reinforces Europe’s strength in the market. These companies are actively participating in innovation through the development of innovative diagnostic solutions, thereby aiding in market growth.
   

Germany companion animal diagnostics market is anticipated to witness lucrative growth over the analysis period in overall Europe region.
 

• As of 2023, 45% of German households have a pet and 14% of households have two pets or more. This totals approximately 34.3 million pets. Cats and dogs are the most popular house pets, with 25% of German households owning cats and 21% of households owning dogs.
   
• The rising adoption of pet animals, high awareness among pet owners, and surging expenditure on veterinary care are set to augment the market size in Germany.
   
• Germany’s role as a hub for innovation in veterinary diagnostics further solidifies its position as a leader in the market, catering to both domestic and international demand for reliable and efficient veterinary solutions.
   

The Asia Pacific companion animal diagnostics market is anticipated to witness significant growth over the analysis timeframe.
 

• The Asia Pacific region holds a high growth potential in the global market, driven by advancements in veterinary healthcare infrastructure, increasing pet ownership, and growing awareness of preventive diagnostic testing.
   
• As economies in countries like China, India, and Japan continue to expand, there is a rising demand for high-quality veterinary care and advanced veterinary diagnostic tools.
   
• The increasing prevalence of diseases in pets, coupled with a shift toward more precise and effective treatment options, further fueling the market's growth in the region.
   

India companion animal diagnostics market is predicted to grow significantly over the forecast period.
 

• Rapidly expanding veterinary infrastructure in the country such as veterinary hospitals and clinics, will enhance market growth.
   
• For example, as per Statista, during financial year 2022, over 12,000 veterinary hospitals and polyclinics were found across India. Along with numerous aid centers and dispensaries, accounting nearly 68,000 veterinary institutions were present across the country that year.
   
• Additionally, India has a large pet population with over 31 million pet dogs and 2.4 million pet cats. The increasing pet ownership and rising disposable income in the country, coupled with high expenditure on pet healthcare, will offer lucrative market growth opportunities in the country.
   

Brazil companion animal diagnostics market is experiencing significant growth in the Latin America market due to the increasing demand for advanced diagnostic tools in veterinary care.
 

• Brazil holds a leading position in the Latin American market due to its large pet population and increasing investment in veterinary healthcare. With one of the highest numbers of dogs and cats per household in the region, the demand for quality diagnostic services continues to grow.
   
• For example, Brazil has the third-largest pet population in the world, with 160 million pets, of which 60 million are dogs, 30 million cats, and 32 million pet-owning households.
   
• The country also benefits from a relatively advanced veterinary infrastructure compared to other Latin American nations. Brazil has a broad network of veterinary clinics, diagnostic laboratories, and universities that support research and development in animal health.
   
• The presence of both local and international diagnostic companies has led to the increased availability of modern testing technologies, such as point-of-care diagnostics and molecular testing, further driving the market growth.
   

South Africa holds the largest market share in the Middle East and Africa companion animal diagnostics market.
 

• The country has a sizable population of companion animals, particularly in urban and suburban areas where pet ownership is more common and veterinary services are more accessible. For example, in South Africa, there were an estimated 21.7 million pets in 2023, according to GlobalPETS.
   
• As pet owners increasingly prioritize preventive care, routine diagnostic testing such as blood work, urinalysis, and screening becomes more frequent, thereby directly contributing to the high demand for diagnostic services and products.
   

Companion Animal Diagnostics Market Share

Competition in the companion animal diagnostics industry is characterized by the presence of dominant global players alongside several regional and local market players. The top 4 players, such as IDEXX Laboratories, Zoetis, Thermo Fisher Scientific, and Heska Corporation, account for approximately 60%-65% of the global market owing to their extensive product offerings, global reach, and continuous investments in advanced diagnostic technologies. These key players focus on various strategies such as acquisitions, business expansion, and novel product launches to consolidate their market presence.
 

Additionally, there are several local and regional players operating in the market who are boosting competition by providing affordable options at lower costs. These players are also involved in several strategies such as mergers, acquisitions, and novel product launches to expand their product offerings.
 

Companion Animal Diagnostics Market Companies

Few of the prominent players operating in the companion animal diagnostics industry include:

• bioMerieux
• BioNote
• Bio-Rad Laboratories
• Boehringer Ingelheim International
• Heska Corporation (Mars)
• Idexx laboratories
• KogeneBiotech
• Median Diagnostics
• Neogen Corporation
• Randox
• Thermo Fischer Scientific
• Virbac
• VetAll Laboratories
• Qiagen
• Zoetis

• IDEXX Laboratories is one of the leading players in the market, commanding a significant share in the global market, supported by its robust in-clinic analyzers and consumables. The company continues to drive growth through innovation, including AI-powered tools like the inVue Dx analyzer and its upcoming Cancer Dx screening, while bolstering recurring revenue via its consumable ecosystem.
   
• Zoetis is one of the key players in the companion animal diagnostics market, leveraging its strong research capabilities and strategic acquisitions to expand its diagnostic offerings. With innovative tools like blood glucose and chemistry analyzers, rapid immunoassays, and a focus on point-of-care solutions, Zoetis is enhancing diagnostic efficiency for veterinarians and driving growth in the companion animal segment.
   

Companion Animal Diagnostics Industry News

• In June 2024, IDEXX Laboratories announced the launch of the Catalyst Pancreatic Lipase Test, a new diagnostic tool designed to detect pancreatitis in dogs and cats rapidly and accurately. This test provides quantitative results in under 10 minutes at the point-of-care, enabling veterinarians to confidently diagnose or rule out pancreatitis during the patient visit and initiate timely treatment.
   
• In April 2023, bioMerieux and Oxford Nanopore entered into a strategic partnership agreement to develop innovative infectious disease diagnostics. This strategy will help the company to develop innovative solution in in vitro diagnostics for infectious disease detection and strengthen business relations.
   
• In September 2022, Zoetis Inc. acquired NewMetrica, a pioneering Scottish company that has developed state-of-the-art digital instruments. This strategy helped the company to enhance companion animal portfolio and consolidate the market position in animal diagnostics industry.
   
• In June 2021, IDEXX Laboratories, Inc. announced the acquisition of rVetLink, a company that is involved in cloud-based software technology and providing referral management solutions for veterinary specialty care hospitals. This acquisition will expand the company’s portfolio of cloud technology offerings for the veterinary industry.
   

The companion animal diagnostics market research report includes in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Consumables
• Instruments

Market, By Technology

• Clinical biochemistry 
  • Glucose monitoring
  • Blood gas and electrolyte analysis
  • Other clinical biochemistry tests         
• Immunodiagnostics 
  • Lateral flow assays
  • ELISA
  • Immunoassay analyzers
  • Other immunodiagnostic tests
• Molecular diagnostics
  • PCR
  • Microarrays
  • Other molecular diagnostic tests
• Hematology
• Urinalysis
• Other technologies

Market, By Application

• Bacteriology
• Pathology
• Parasitology
• Other applications

Market, By Animal Type

• Dogs
• Cats
• Horses
• Other animal types

Market, By End Use

• Veterinary hospitals and clinics
• Diagnostic labs
• Home care settings
• Other end use

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Poland
  • Netherlands
  • Sweden
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Philippines
  • Thailand
  • Indonesia 
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Peru
  • Chile 
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Turkey
  • Egypt
  • Israel